Medical/Pharmaceuticals Newswire
Array BioPharma to Present at the Piper Jaffray Health Care Conference
BOULDER, Colo.-(Business Wire)-November 20, 2008 -
Luminex Corporation and Mingyuan Medicare Development Company Sign Distribution Agreement
AUSTIN, Texas & HONG KONG-(Business Wire)-November 20, 2008 -
Vienna to Host BIO-Europe 2009
ZURICH, Switzerland & CARLSBAD, Calif. & VIENNA, Austria-(Business Wire)-November 20, 2008 -
TruthAboutProbiotics.com Helps Separate Fact From Fiction
WESTLAKE VILLAGE, Calif.-(Business Wire)-November 20, 2008 -
Natrol® JuiceFestiv™ -- The Ultimate Fruit and Veggie Superfood™ -- Now Available at Approximately 200 U.S. Sam’s Club® Stores
CHATSWORTH, Calif.-(Business Wire)-November 20, 2008 -
OSI Pharmaceuticals to Present at the Piper Jaffray Health Care Conference on Tuesday, December 2, 2008
MELVILLE, N.Y.-(Business Wire)-November 20, 2008 -
Research and Markets: An Essential Report on Why Drugs Fail
DUBLIN, Ireland-(Business Wire)-November 20, 2008 -
Research and Markets: Examine the UK Hayfever Remedies, 2008 With This Essential Report
DUBLIN, Ireland-(Business Wire)-November 20, 2008 -
BioReliance Announces First Commercial Use of HyMy™ Assay
ROCKVILLE, Md.-(Business Wire)-November 20, 2008 -
China Yongxin Pharmaceuticals Announces Record Revenue and Net Income for Third Quarter 2008
CHANGCHUN, China & LOS ANGELES-(Business Wire)-November 20, 2008 -
Gloucester Pharmaceuticals to Present Positive Results from Multiple Romidepsin Clinical Trials at the ASH Annual Meeting
CAMBRIDGE, Mass.-(Business Wire)-November 20, 2008 -
Adimab, Inc. Announces Series C Financing
LEBANON, N.H.-(Business Wire)-November 20, 2008 -
Thought Leaders from Burzynski Research Institute, Inc. Present Encouraging Data on Antineoplastons for Treatment of Malignant Gliomas
HOUSTON & LAS VEGAS-(Business Wire)-November 20, 2008 -
Provectus Lead Investigator Professor John F. Thompson Gives Update on PV-10 Melanoma Study at Clinical Oncological Society of Australia 2008 Annual Scientific Meeting
KNOXVILLE, Tenn.-(Business Wire)-November 20, 2008 -
Drugs.com Helps Seniors Reduce Their Prescription Drug Costs
NEW YORK-(Business Wire)-November 20, 2008 -
Morphotek®, Inc. Receives Additional $1.6M in Funding from The U.S. Department of Defense to Develop Therapeutic Antibodies Against Microbial Bioweapons
EXTON, Pa.-(Business Wire)-November 20, 2008 -
Targacept Scientists Make Multiple Presentations at Society for Neuroscience Supporting the Potential of NNR Therapeutics to Treat CNS Diseases and Disorders
WINSTON-SALEM, N.C.-(Business Wire)-November 20, 2008 -
PharmaNet Development Group Announces Exchange Offer for Its Outstanding 2.25% Convertible Senior Notes Due 2024
PRINCETON, N.J.-(Business Wire)-November 20, 2008 -
Oscient Pharmaceuticals Announces Determination of the Consideration Issuable in its Exchange Offer
WALTHAM, Mass.-(Business Wire)-November 20, 2008 -
LifeCycle Pharma A/S to Host Conference Call Announcing Interim Results for the Third Quarter of 2008
HØRSHOLM, Denmark-(Business Wire)-November 20, 2008 -
Ardea Biosciences to Present at the 20th Annual Piper Jaffray Healthcare Conference
SAN DIEGO-(Business Wire)-November 20, 2008 -
National Neurovision Research Institute (NNRI) and Resolvyx Pharmaceuticals Collaborate to Assess Resolvins to Treat Degenerative Eye Diseases
OWINGS MILLS, Md. & BEDFORD, Mass.-(Business Wire)-November 20, 2008 -
Resolvyx Announces Open IND for RX-10045, the Lead Resolvin Therapeutic for Dry Eye
BEDFORD, Mass.-(Business Wire)-November 20, 2008 -
Invitrogen and Applied Biosystems Announce Preliminary Results of Election Regarding Merger Consideration
CARLSBAD, Calif. & NORWALK, Conn.-(Business Wire)-November 20, 2008 -
Clinical Data Participates in MAb IMPACT Meeting to Improve Clinical Efficacy of Monoclonal Antibodies for Cancer Treatment
NEWTON, Mass.-(Business Wire)-November 20, 2008 -
Learn about the World Regenerative Medicine Market
NEW YORK-(Business Wire)-November 20, 2008 -
Cougar Biotechnology Announces Initiation of Phase I/II Trial of CB7630 (Abiraterone Acetate) in Advanced Breast Cancer Patients
LOS ANGELES-(Business Wire)-November 20, 2008 -
Arcutis Pharmaceuticals Announces FDA Approval of Acanya™ Gel for the Treatment of Acne
REDWOOD CITY, Calif.-(Business Wire)-November 20, 2008 -
Dr. Etienne Gagnon Receives CIHR BIOTECanada/Schering-Plough Canada Fellowship for Innovative Cancer Research
OTTAWA-(Business Wire)-November 20, 2008 -
Affymax Announces Another Favorable Data Monitoring Committee Review of Phase 3 Hematide Program
PALO ALTO, Calif.-(Business Wire)-November 20, 2008 -
Alnylam Presents Pre-clinical Data from TTR Amyloidosis Development Program
CAMBRIDGE, Mass.-(Business Wire)-November 20, 2008 -
Open-source Analysis Tool enables Rapid Annotation of Metagenomes
BRANFORD, Conn.-(Business Wire)-November 20, 2008 -
Synta Pharmaceuticals Announces First Patient Treated in Phase 1/2 Clinical Trial of Elesclomol in Prostate Cancer
LEXINGTON, Mass.-(Business Wire)-November 20, 2008 -
Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors
CAMBRIDGE, Mass.-(Business Wire)-November 20, 2008 -
Pro-Pharmaceuticals Files Registration Statement for Rights Offering to Its Shareholders
NEWTON, Mass.-(Business Wire)-November 20, 2008 -
Akorn Enters into a Five Year Contract Manufacturing Agreement to Supply an Ophthalmic Product
LAKE FOREST, Ill.-(Business Wire)-November 20, 2008 -
ImClone Systems’ State-of-the-Art Manufacturing Facility Receives FDA Approval for Multi-Product Biologics Production
NEW YORK-(Business Wire)-November 20, 2008 -
Pfizer Withdraws Application to Switch Viagra to Non-Prescription Status in Europe
NEW YORK-(Business Wire)-November 20, 2008 -
Teva Provides Update on Generic Pulmicort Respules® Launch
JERUSALEM-(Business Wire)-November 20, 2008 -
Carlos V. Paya, MD, PhD, to Join Elan as Company President
DUBLIN, Ireland & SAN FRANCISCO & NEW YORK-(Business Wire)-November 20, 2008 -
Advanced Medical Institute Inc. Announces Results for the Quarter Ended September 30, 2008
SYDNEY, Australia-(Business Wire)-November 20, 2008 -
Mannatech Declares Dividend
COPPELL, Texas-(Business Wire)-November 19, 2008 -
PDI Names Veronica A. Lubatkin to Board of Directors
SADDLE RIVER, N.J.-(Business Wire)-November 19, 2008 -
Neuro-Hitech, Inc. Announces Modification of Terms of Acquisition of MCR American Pharmaceuticals and AMBI Pharmaceuticals
NEW YORK-(Business Wire)-November 19, 2008 -
Charles River Promotes Foster Jordan to Corporate Senior Vice President
WILMINGTON, Mass.-(Business Wire)-November 19, 2008 -
Invitrogen Launches In Vivo RNAi Delivery Reagent
CARLSBAD, Calif.-(Business Wire)-November 19, 2008 -
Gentium Provides an Update on the Phase 3 Treatment Trial of Defibrotide for Severe Veno-Occlusive Disease
VILLA GUARDIA, Italy-(Business Wire)-November 19, 2008 -
CareMore’s Medicare Health Plan Named “Best Value” in 2009 Senior Choice Gold Award
SAN JOSE, Calif.-(Business Wire)-November 19, 2008 -
BioDelivery Sciences Remains on Schedule for December ONSOLIS Resubmission Following Meeting with FDA
RALEIGH, N.C.-(Business Wire)-November 19, 2008 -
PBMI Conference Tackles Market Forces That Impact Drug Benefit ROI
SCOTTSDALE, Ariz.-(Business Wire)-November 19, 2008 -
Research and Markets: Serbia Pharmaceuticals and Healthcare Report Q4 2008 Provides Independent Forecasts And Competitive Intelligence
DUBLIN, Ireland-(Business Wire)-November 19, 2008 -
Covidien Launches Improved Magellan Safety Hypodermic Needle
MANSFIELD, Mass.-(Business Wire)-November 19, 2008 -
A Pharma Poland Online Subscription: Gain an Insight into the Market with Over 120 Industry Updates, and News on Manufacturers and Research Developments
DUBLIN, Ireland-(Business Wire)-November 19, 2008 -
TaconicArtemis Announces Publication in PNAS: Inducible Gene Silencing in Transgenic Rats via RNAi
COLOGNE, Germany-(Business Wire)-November 19, 2008 -
Research and Markets: Ukraine Pharma - New Opportunities for Growth Gives An Extensive And Objective Analysis On The Pharmaceutical Market Of Ukraine
DUBLIN, Ireland-(Business Wire)-November 19, 2008 -
Nymox Announces NEXUS-1 and NEXUS-2 Phase 3 Trials for NX-1207 Investigational Drug for BPH
HASBROUCK HEIGHTS, N.J.-(Business Wire)-November 19, 2008 -
Research and Markets: This Essential Report on the Malaysian Pharmaceuticals and Healthcare Industry is Now Available
DUBLIN, Ireland-(Business Wire)-November 19, 2008 -
Research and Markets: Drug Target Analytical Report: HCRTR1 - An Insight into Pathways, Disease Associations, Competitive Landscape, Chemotypes, Discovery Pipeline, and Marketed Drugs
DUBLIN, Ireland-(Business Wire)-November 19, 2008 -
MIT Holding Inc. Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2008
SAVANNAH, Ga.-(Business Wire)-November 19, 2008 -
KAI Reports Positive Preclinical Results for KAI-1678, First-in-Class Compound to Treat Pain
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-November 19, 2008 -
ProTrials Wins Stevie® Award For Women In Business
MOUNTAIN VIEW, Calif. & NEW YORK-(Business Wire)-November 19, 2008 -
Applied NeuroSolutions’ Q3 2008 Alzheimer’s Disease Serum Diagnostic Development Program Update
VERNON HILLS, Ill.-(Business Wire)-November 19, 2008 -
Walgreens Offers Help Sorting Through Changes to Medicare Part D Plans
DEERFIELD, Ill.-(Business Wire)-November 19, 2008 -
New Study Proves Protandim® Produces 300% Increase in Glutathione, a Key Antioxidant and Anti-aging Factor
SAN DIEGO-(Business Wire)-November 19, 2008 -
Konstantinos Andrikopoulos, Ph.D., J.D., Joins RXi Pharmaceuticals as VP, Legal Counsel & Chief IP Counsel
WORCESTER, Mass.-(Business Wire)-November 19, 2008 -
Pervasis Therapeutics Announces Promising Efficacy Results from Phase 1 and 2 Clinical Trials of Vascugel® in Dialysis Patients Needing Permanent AV Access, Data Builds on Compelling Safety Findings
NEW YORK-(Business Wire)-November 19, 2008 -
Research and Markets: Hungary Pharmaceuticals and Healthcare Report Q4 2008 Report - OEP Announced That Is Set To Make A Profit Of Up To HUF10bn (US$67mn) In the Current Year
DUBLIN, Ireland-(Business Wire)-November 19, 2008 -
Merge Healthcare Releases Updated DICOM Toolkit
MILWAUKEE-(Business Wire)-November 19, 2008 -
Elixir Pharmaceuticals’ Phase III Trial of Metformin-Mitiglinide Combination Therapy Demonstrates Significant Reductions in HbA1c (Blood Glucose) Levels Compared to Type 2 Diabetes Patients Not Well-Controlled on Metformin Alone
CAMBRIDGE, Mass.-(Business Wire)-November 19, 2008 -
A Bulgaria Pharmaceuticals and Healthcare Report for Q4 2008: Examine the Effect of Current Reforms, Industry Developments and Detailed Forecasts
DUBLIN, Ireland-(Business Wire)-November 19, 2008 -
Randomized Phase 2 Study of IMC-A12 for HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment
NEW YORK-(Business Wire)-November 19, 2008 -
GenVec Announces Interim Survival Data in Pivotal Trial of TNFerade™ in Locally Advanced Pancreatic Cancer
GAITHERSBURG, Md.-(Business Wire)-November 19, 2008 -
Titan Pharmaceuticals Presents Phase 3 Data for Probuphine® at the 2008 International Society of Addiction Medicine Congress
SOUTH SAN FRANCISCO, Calif & CAPE TOWN, South Africa-(Business Wire)-November 19, 2008 -
Knopp Neurosciences Completes Series B2 Financing, Raising Total Capitalization to $27 Million
PITTSBURGH-(Business Wire)-November 19, 2008 -
Viral Genetics, Inc. Completes Acquisition of V-Clip Pharmaceuticals, Inc.
SAN MARINO, Calif.-(Business Wire)-November 19, 2008 -
Teva Receives First U.S. Approval for Generic Pulmicort Respules®; Commences Commercial Launch
JERUSALEM-(Business Wire)-November 19, 2008 -
AMRI Announces Agreement with Teva Pharmaceuticals and Barr Laboratories to Settle Litigation in ALLEGRA® and ALLEGRA®D-12 U.S. Patent Dispute
ALBANY, N.Y.-(Business Wire)-November 19, 2008 -
Teva Announces Agreement on Allegra® Patent Challenge
JERUSALEM-(Business Wire)-November 19, 2008 -
Emergent BioSolutions to Webcast Presentation at the 6th Annual Southwestern Showcase Investor Conference on November 20, 2008
ROCKVILLE, Md.-(Business Wire)-November 18, 2008 -
NitroMed and Archemix Announce Merger Agreement
LEXINGTON, Mass. & CAMBRIDGE, Mass.-(Business Wire)-November 18, 2008 -
ReGen Biologics Collagen Scaffold Receives Positive Orthopaedic Panel Recommendations
HACKENSACK, N.J.-(Business Wire)-November 18, 2008 -
IMPAX Sued Based on ANDA for Generic Cymbalta®
HAYWARD, Calif.-(Business Wire)-November 18, 2008 -
Telephone Counseling May Improve Effectiveness of Varenicline (Chantix™), According to Free & Clear® Study
SEATTLE-(Business Wire)-November 18, 2008 -
LifeVantage Corporation Announces 1Q FY 2009 Financial and Operating Results
SAN DIEGO-(Business Wire)-November 18, 2008 -
UnitedHealth Group to Provide Immediate Resources for Those Affected by the Southern California Wildfires
LOS ANGELES-(Business Wire)-November 18, 2008 -
FDA Extends METOZOLV™ ODT Review Date
RALEIGH, N.C.-(Business Wire)-November 18, 2008 -
New Study Highlights Rising Number of Type 2 Diabetes Patients in U.S., Increasing Complexity of Treatments
NORWALK, Conn.-(Business Wire)-November 18, 2008 -
Allion Healthcare Announces Partnership with Under One Roof to Service Patients in San Francisco
MELVILLE, N.Y.-(Business Wire)-November 18, 2008 -
Patient Enrollment Begins in Exploratory Phase II Trial of NovaBay's Lead Aganocide Compound, NVC-422, in Catheter-Associated Urinary Tract Infections
EMERYVILLE, Calif.-(Business Wire)-November 18, 2008 -
GE Healthcare Announces Three Groundbreaking Digital Programs with Leading Medical Institutions
NEW YORK-(Business Wire)-November 18, 2008 -
Salix Announces Issuance of U.S. Patent for Rifaximin
RALEIGH, N.C.-(Business Wire)-November 18, 2008 -
CytoGenix, Inc. Board Appoints Industry Veteran Lex M. Cowsert, PhD as President, Chief Executive Officer and Director
HOUSTON-(Business Wire)-November 18, 2008 -
Economist Finds Flaws in 14-Year Data Exclusivity Claim for Biogenerics
WASHINGTON-(Business Wire)-November 18, 2008 -
Health Net of Oregon Reminds Adults: Vaccines Aren’t Just for Kids
TIGARD, Ore.-(Business Wire)-November 18, 2008 -
Understand How U.S. Pharmaceutical and Biotechnology Organizations Can Optimize Their CI Operations While Working Within Defined Guidelines
DUBLIN, Ireland-(Business Wire)-November 18, 2008 -
New Publication Shows Angiomax Significantly Reduces Initial Hospital Costs by $572 Per Patient Compared to Conventional Therapy in Moderate and High-Risk ACS Patients
PARSIPPANY, N.J.-(Business Wire)-November 18, 2008 -
Aethlon Medical Releases Shareholder Letter
SAN DIEGO-(Business Wire)-November 18, 2008 -
NeurAxon, Inc. to Present at 20th Annual Piper Jaffray Health Care Conference December 2, 2008
WALTHAM, Mass.-(Business Wire)-November 18, 2008 -
Mintz Levin Represents Genelabs Technologies in $57M Deal with GlaxoSmithKline
BOSTON-(Business Wire)-November 18, 2008 -
Blue Vector Opens Platform to Third-Party Developers
PALO ALTO, Calif.-(Business Wire)-November 18, 2008 -
Hospitals, Healthcare Providers to Save with Premier's New General Laboratory Products, Equipment and Service Agreement
CHARLOTTE, N.C.-(Business Wire)-November 18, 2008 -
Immunosyn Corporation Files 10-Q
LA JOLLA, Calif.-(Business Wire)-November 18, 2008 -
Aperio Receives Second FDA Clearance for Diagnosis of Digital Breast Cancer Slides
VISTA, Calif.-(Business Wire)-November 18, 2008 -
Research and Markets: Through This Report, Executives at Leading Biopharmaceutical Companies Shared Reasons Why Work Done Through Early Commercialization Groups is Invaluable
DUBLIN, Ireland-(Business Wire)-November 18, 2008 -
Halloran Consulting Group Appoints Industry Veterans in Quality Systems and Training Practice Areas
BOSTON-(Business Wire)-November 18, 2008 -
NexMed Approved to Sell N.J. Tax Credits
EAST WINDSOR, N.J.-(Business Wire)-November 18, 2008 -
Research Provides Further Evidence for the Mechanism of Action Underlying Hythiam’s PROMETA® Treatment Program
LOS ANGELES-(Business Wire)-November 18, 2008 -
Health Net of the Northeast Reminds Adults: Vaccines Aren’t Just for Kids
SHELTON, Conn.-(Business Wire)-November 18, 2008 -
Geron Corporation to Present at Lazard Capital Markets Healthcare Conference
MENLO PARK, Calif.-(Business Wire)-November 18, 2008 -
Provectus Lead Investigator Professor John F. Thompson to Present at Clinical Oncological Society of Australia 2008 Annual Scientific Meeting on November 19, 2008
KNOXVILLE, Tenn.-(Business Wire)-November 18, 2008 -
Catalent Introduces the Secure-Vial™ Technology for Innovative and Cost Effective Delivery of Injectable Pharmaceuticals
SOMERSET, N.J.-(Business Wire)-November 18, 2008 -
Study Published in Archives of Surgery Demonstrated Benefit of ENTEREG® (alvimopan) in Postoperative Ileus
EXTON, Pa. & PHILADELPHIA-(Business Wire)-November 18, 2008 -
High Growth Reported for the World Pharmaceuticals Market Brief
NEW YORK-(Business Wire)-November 18, 2008 -
Lilly Selects ICON to Manage its Clinical Data Management Business Outside the US
DUBLIN, Ireland-(Business Wire)-November 18, 2008 -
NuGEN Expands Executive Team With Finance and Marketing Pros
SAN CARLOS, Calif.-(Business Wire)-November 18, 2008 -
New Study Reaffirms Quick-Med’s NIMBUS® Technology Poses No Threat of Bacterial Resistance
GAINESVILLE, Fla.-(Business Wire)-November 18, 2008 -
Numerate Completes $4 Million Financing
SAN BRUNO, Calif.-(Business Wire)-November 18, 2008 -
Teva Completes Enrollment in Laquinimod Phase III Clinical Trial
JERUSALEM & LUND, Sweden-(Business Wire)-November 18, 2008 -
Topical Dermatology Drug Developer Sol-Gel Raises $9 Million
REHOVOT, Israel-(Business Wire)-November 18, 2008 -
Gut Check Reveals Vast Multicultural Community of Bugs in Bowels, Stanford Scientists Say
STANFORD, Calif.-(Business Wire)-November 18, 2008 -
ImClone Systems Announces Clearance of Tender Offer by German Federal Cartel Office
NEW YORK-(Business Wire)-November 17, 2008 -
Genentech Issues Dear Healthcare Provider Letter Regarding a 2nd Case of PML in a Raptiva Patient
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-November 17, 2008 -
Merck Announces Voluntary Delisting from Philadelphia Stock Exchange
WHITEHOUSE STATION, N.J.-(Business Wire)-November 17, 2008 -
Celgene Corporation to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
SUMMIT, N.J.-(Business Wire)-November 17, 2008 -
PDI Appoints Pharma Industry Veteran Nancy Lurker as Chief Executive and Director
SADDLE RIVER, N.J.-(Business Wire)-November 17, 2008 -
Genzyme and the International Center for Genetic Engineering and Biotechnology Form Collaboration to Advance Treatments for Neglected Diseases
CAMBRIDGE, Mass. & TRIESTE, Italy-(Business Wire)-November 17, 2008 -
Acusphere, Inc. Announces Resignation of Howard Bernstein
WATERTOWN, Mass.-(Business Wire)-November 17, 2008 -
Fitch Revises Merck & Co.'s Ratings Outlook to Negative
CHICAGO-(Business Wire)-November 17, 2008 -
Averion International Reports 2008 Third Quarter Financial Results
SOUTHBOROUGH, Mass.-(Business Wire)-November 17, 2008 -
CIGNA Offers Assistance to Individuals Impacted by California Wildfires
PHILADELPHIA-(Business Wire)-November 17, 2008 -
Celprogen Introduces an in vivo Model for Human Brain Cancer (Human Glioblastoma GBM) for Drug Discovery Applications
SAN PEDRO, Calif.-(Business Wire)-November 17, 2008 -
Maas Biolab Scientists Validate Cyclosporin Human Neuroprotection
ALBUQUERQUE, N.M.-(Business Wire)-November 17, 2008 -
Bio-Path Holdings, Inc. Announces the Signing of a Drug Manufacturing Agreement with Althea Technologies, Inc.
HOUSTON-(Business Wire)-November 17, 2008 -
Herbalife Opens 70th market in Ecuador
LOS ANGELES-(Business Wire)-November 17, 2008 -
Clinilabs Appoints Senior Medical Director of Clinical Pharmacology Unit (CPU)
NEW YORK-(Business Wire)-November 17, 2008 -
World's Most Prominent Pharmaceutical Scientists to Present Studies Shaping the Industry’s Future
ATLANTA-(Business Wire)-November 17, 2008 -
Wolters Kluwer Health Expands Tall Man Drug Name Lettering in Medi-Span Drug Information Databases
INDIANAPOLIS-(Business Wire)-November 17, 2008 -
New Certification in Medical Publications Planning Reinforces Professional Credibility and Integrity
BRIARCLIFF MANOR, N.Y.-(Business Wire)-November 17, 2008 -
Altus Pharmaceuticals Reaffirms Plan to Submit New Drug Application for Trizytek Approval
WALTHAM, Mass.-(Business Wire)-November 17, 2008 -
Richard Hollis, Chairman, President and CEO of Hollis-Eden Pharmaceuticals Talks to The Wall Street Transcript
NEW YORK-(Business Wire)-November 17, 2008 -
Identigene Expands Sales of First-ever Over-the-Counter DNA Paternity Test Kit to Discount Stores and Supercenters
SALT LAKE CITY-(Business Wire)-November 17, 2008 -
Gamma Pharmaceuticals Receives Purchase Orders from a National Retail Pharmacy Chain
LAS VEGAS-(Business Wire)-November 17, 2008 -
Applied NeuroSolutions Announces Addition of Healthcare Financial Executive Gary C. Parks to Board of Directors
VERNON HILLS, Ill.-(Business Wire)-November 17, 2008 -
Never Forget to Take Medication Again: Vitality GlowCaps Now Available on Amazon.com
BOSTON-(Business Wire)-November 17, 2008 -
GeneLink Reports Record Third Quarter Results, Revenues Exceed $1.8M
ORLANDO, Fla.-(Business Wire)-November 17, 2008 -
InteRNA Technologies and Cenix BioScience Ink Research Agreement for miRNA Drug Discovery
BILTHOVEN, The Netherlands & DRESDEN, Germany-(Business Wire)-November 17, 2008 -
Myozyme Produced at the 2000 L Bioreactor Scale to Receive Accelerated Approval
CAMBRIDGE, Mass.-(Business Wire)-November 17, 2008 -
University of Dallas Announces Plans to Establish North Texas Region's First School of Pharmacy
IRVING, Texas-(Business Wire)-November 17, 2008 - The University of Dallas (UD) announced today its plans to develop North Texas' first professional doctor of pharmacy (Pharm.D.) degree program. The Dallas-Fort Worth Metroplex, the fourth-largest metropolitan area in the U.S., is the largest...
Nutra Pharma Announces Provision of RPI-78M under Compassionate Release to Adrenomyeloneuropathy (AMN) Patients
BOCA RATON, Fla.-(Business Wire)-November 17, 2008 -
Meridian Bioscience to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
CINCINNATI-(Business Wire)-November 17, 2008 -
Research and Markets: Analyse the 'IT Selling Opportunities Map' for Hardware, Software and IT Services for Pfizer Today
DUBLIN, Ireland-(Business Wire)-November 17, 2008 -
Alkermes Presents Positive Preclinical Data on Novel, Proprietary Molecule Designed to Improve Outcomes for Patients Taking Opioid Analgesics
CAMBRIDGE, Mass.-(Business Wire)-November 17, 2008 -
Dicerna Co-Founder and Scientific Advisory Board Chair to Present at American Association of Pharmaceutical Scientists 2008 Meeting and Exposition
WATERTOWN, Mass.-(Business Wire)-November 17, 2008 -
Juanell Hefner Named President of MHN
SAN RAFAEL, Calif.-(Business Wire)-November 17, 2008 -
Patients Experienced Nearly a 70% Reduction in Pain When Using MPM Medical's Regenecare Wound Care Gel
IRVING, Texas-(Business Wire)-November 17, 2008 -
Cenomed BioSciences Presents Data on New Drug Candidates at the Society for Neuroscience in Washington DC
IRVINE, Calif.-(Business Wire)-November 17, 2008 -
Wall Street Analyst Forum 2008 Presenter Profiles
NEW YORK-(Business Wire)-November 17, 2008 -
Affymax Completes Enrollment in Phase 3 Program for Hematide in Chronic Renal Failure with Completion of Enrollment in EMERALD 2, the Final of Four Phase 3 Clinical Trials of Hematide(TM)
PALO ALTO, Calif.-(Business Wire)-November 17, 2008 -
BioSante Pharmaceuticals Announces Receipt of NIH Grant for Inhaled Interferon
LINCOLNSHIRE, Ill.-(Business Wire)-November 17, 2008 -
Cegedim Dendrite and Skila Offer Life Sciences-Specific Tool for Effective Opinion Leader Management
PARIS & MORRIS PLAINS, N.J.-(Business Wire)-November 17, 2008 -
etrials Announces Enhanced 3-Year Agreement with Peak 10
RALEIGH, N.C.-(Business Wire)-November 17, 2008 -
Progenics Announces Wyeth Has Received RELISTOR Approval in Australia
TARRYTOWN, N.Y.-(Business Wire)-November 17, 2008 -
Rexahn Pharmaceuticals Strengthens Clinical Development Leadership with Formation of Oncology Scientific Advisory Board
ROCKVILLE, Md.-(Business Wire)-November 17, 2008 -
Provectus Pharmaceuticals Adds Sixth Center to Phase 2 Clinical Trial of PV-10
KNOXVILLE, Tenn.-(Business Wire)-November 17, 2008 -
Life Science Pharmaceuticals Enters Into Agreement with Abbott to Develop Antibody 806
GREENWICH, Conn.-(Business Wire)-November 17, 2008 -
APR Applied Pharma Research and Fidia Farmaceutici Receive IND Approval from FDA for a New NSAID Matrix Patch Product
BALERNA, Switzerland & ABANO TERME (PD), Italy-(Business Wire)-November 17, 2008 -
ZIOPHARM Oncology Presents Positive Data from Studies of Palifosfamide
LONDON-(Business Wire)-November 17, 2008 -
Broad Institute of MIT and Harvard Ramps Up Cancer Research by Expanding Its Fleet of SOLiD™ Systems From Applied Biosystems
FOSTER CITY, Calif.-(Business Wire)-November 17, 2008 -
Ascent Therapeutics Debuts with the Appointment of CEO and Head of Discovery Research
CAMBRIDGE, Mass.-(Business Wire)-November 17, 2008 -
Covidien Reports Fourth-Quarter and Fiscal 2008 Results
HAMILTON, Bermuda-(Business Wire)-November 17, 2008 - Covidien Ltd. (NYSE: COV; BSX: COV) today reported results for the fourth quarter of fiscal 2008 (July - September 2008). Fourth-quarter net sales rose 12% to $2.6 billion from $2.3 billion a year ago, fueled by strong growth in the Medical...
Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7%
SAN DIEGO-(Business Wire)-November 17, 2008 -
CEO Increases Shareholding in Meda
STOCKHOLM, Sweden-(Business Wire)-November 17, 2008 -
Roche, Merck Serono and Abbott Join Forces in Biotechnology Cluster Rhine-Neckar (BioRN)
MANNHEIM, Germany-(Business Wire)-November 17, 2008 -
Meda: European Collaboration Agreement in Dermatology
STOCKHOLM, Sweden-(Business Wire)-November 17, 2008 -
Biothera Expertise in Carbohydrate Characterization Highlighted
EAGAN, Minn.-(Business Wire)-November 17, 2008 -
Midatech forms PharMida AG, a New Life Science Subsidiary Applying Nanotechnology to Drug Discovery and Development
OXFORD, England-(Business Wire)-November 17, 2008 -
Biodel Reports Protective Effects of VIAject(TM) Insulin on Microvascular Function in Patients with Type 2 Diabetes
DANBURY, Conn.-(Business Wire)-November 15, 2008 - Biodel Inc. (Nasdaq: BIOD) today reported positive effects of VIAject(TM) insulin on microvascular function in patients with Type 2 diabetes which were superior to results seen with regular human insulin and insulin lispro. Professor Thomas Forst...
Omnicare Announces Resignation of Jeffrey W. Ubben from Board of Directors
COVINGTON, Ky.-(Business Wire)-November 14, 2008 - Omnicare, Inc. (NYSE:OCR), one of the nation's leading providers of pharmaceutical care for the elderly, today announced that Jeffrey W. Ubben, founder, chief executive officer and chief investment officer of ValueAct Capital, has resigned as a...
HBIO Appoints McNaughton New CFO
HOLLISTON, Mass.-(Business Wire)-November 14, 2008 - Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, today announced the hiring and appointment of Thomas McNaughton as its new Chief Financial...
ARYx Therapeutics Presents Clinical Data for ATI-5923 at American Heart Association Scientific Sessions 2008
NEW ORLEANS-(Business Wire)-November 14, 2008 - ARYx Therapeutics (NASDAQ:ARYX) announced today that clinical data for ATI-5923, a novel vitamin K epoxide reductase (VKOR) inhibitor in Phase 2/3 development for the treatment of patients at risk of forming dangerous blood clots, were presented this...
IMPAX to Webcast Presentation to Analysts on November 17, 2008
HAYWARD, Calif.-(Business Wire)-November 14, 2008 - IMPAX Laboratories, Inc. today announced that Arthur A. Koch, Jr., its senior vice president and chief financial officer, will provide a review of the information contained in the Company's Form 10 Registration Statement, including a review of...
Dynavax Announces Receipt of Notice of Failure to Satisfy a Continued Listing Rule from The Nasdaq Global Market
BERKELEY, Calif.-(Business Wire)-November 14, 2008 - Dynavax Technologies Corporation (NASDAQ:DVAX) announced today that on November 10, 2008, the Company received a notice from The Nasdaq Stock Market indicating that the Company is not in compliance with the continued listing requirements of The...
Gilead Sciences Announces Notification of ANDA Filing for Truvada
FOSTER CITY, Calif.-(Business Wire)-November 14, 2008 - Gilead Sciences, Inc. (Nasdaq:GILD) today announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA...
PCMA: 'Change to Win' Agenda Will Increase Prescription Drug Costs by $16.1 Billion for New Yorkers
WASHINGTON-(Business Wire)-November 14, 2008 - The Pharmaceutical Care Management Association (PCMA) released the following statement today in response to the agenda being advocated by the group "Change to Win": -0- *T "Pharmacy benefit managers (PBMs) typically reduce drug costs by 25 percent for...
NationsHealth Announces 2008 Third Quarter Financial Results
SUNRISE, Fla.-(Business Wire)-November 14, 2008 - NationsHealth, Inc. (OTCBB:NHRX) ("NationsHealth" or the "Company") today announced its financial results for the quarter and nine months ended September 30, 2008. Revenue for the quarter ended September 30, 2008 increased 39% to $25.3 million...
Luminex Corporation Announces First Commercial Shipment of FLEXMAP 3D Systems
AUSTIN, Texas-(Business Wire)-November 14, 2008 - Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced the commercial sale and shipment of the first FLEXMAP(TM) 3D system manufactured in Austin, Texas. Full market release of the instrument is expected in...
TIGroup Names Thomas Rice to Head Southern Plains Subsidiary in Oklahoma
CHICKASHA, Okla.-(Business Wire)-November 14, 2008 - Tri-Isthmus Group, Inc. (TIGroup) (Pink Sheets:TISG), a provider of financial solutions to the healthcare industry, announced today the appointment of Thomas Rice, an experienced health care executive, to head its Oklahoma-based subsidiary...
Biogen Idec to Present at the Lazard Capital Markets Fifth Annual Life Sciences Conference
CAMBRIDGE, Mass.-(Business Wire)-November 14, 2008 - Biogen Idec Inc. (NASDAQ/BIIB) announced today that its presentation at the Lazard Capital Markets Fifth Annual Life Sciences Conference will be webcast live via the internet, on Wednesday, November 19th, 2008 at 11:00 a.m. ET. To access the...
PBMI Issues Last Call for Rx Benefit Innovation Award Entries
SCOTTSDALE, Ariz.-(Business Wire)-November 14, 2008 - The Pharmacy Benefit Management Institute (PBMI) is accepting final submissions for its 7th annual Rx Benefit Innovation Awards, which showcase innovative solutions to managing cost and quality in drug benefit programs. The deadline for...
Change to Win Coalition Launches National Reform Initiative Focusing On the Pharmacy Benefit Management Business of CVS Caremark
NEW YORK-(Business Wire)-November 14, 2008 - The Change to Win coalition of labor unions held a joint news conference today to discuss the troubling results of an eighteen month investigation into the history and practices of CVS Caremark, and outline an extensive education and reform initiative...
AnaSpec Establishes New Dedicated GMP Manufacturing Facility
SAN JOSE, Calif.-(Business Wire)-November 14, 2008 - In response to increased demand for GMP peptide production, AnaSpec has established a new facility dedicated to GMP manufacturing. Located adjacent to its current San Jose, California-based headquarters, the expansion provides an additional 5000...
Neurologix Announces Third Quarter 2008 Financial Results
FORT LEE, N.J.-(Business Wire)-November 14, 2008 - Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today its financial results for the third quarter and nine months ended September...
INSERTING and REPLACING Medical Connections Holdings, Inc. Reports 58% Increase in Revenue for the Third Quarter 2008
BOCA RATON, Fla.-(Business Wire)-November 14, 2008 - Insert the word "are" in third graph, first sentence as follows: The Company's President, Anthony Nicolosi, said, "We are very excited with our year-to-date results and anticipate similar organic growth in 2009. The corrected release reads...
Javelin Pharmaceuticals Announces 15 Percent Reduction in Workforce
CAMBRIDGE, Mass.-(Business Wire)-November 14, 2008 - Javelin Pharmaceuticals, Inc. (Amex: JAV), a leading developer of novel products for pain management, today announced that it will reduce its workforce by approximately 15 percent. The reduction is intended to reduce Javelin's cost structure...
Nymox Reports Third Quarter 2008 Financial Results
HASBROUCK HEIGHTS, N.J.-(Business Wire)-November 14, 2008 - Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today its financial results for the third quarter of 2008. Nymox reported a net loss of $1,350,536, or $0.05 per share for the quarter ending September 30, 2008, compared to...
NovaBay Pharmaceuticals (NBY) Reports Third Quarter 2008 Financial Results
EMERYVILLE, Calif.-(Business Wire)-November 14, 2008 - NovaBay Pharmaceuticals, Inc. (AMEX: NBY; TSX: NBY, http://www.novabaypharma.com), a clinical stage company developing non-antibiotic anti-infective compounds that do not develop resistance, for the treatment or prevention of a wide range of...
Vertex Pharmaceuticals Announces Webcast of its Presentation at Two Investor Conferences
CAMBRIDGE, Mass.-(Business Wire)-November 14, 2008 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its corporate presentation at the Lazard Capital Markets Healthcare Conference on Wednesday, November 19, 2008 at 2:30 p.m. EST and at the Needham &...
Helicos Launches Open Access Web Site With Microbial Genome Data
CAMBRIDGE, Mass.-(Business Wire)-November 14, 2008 - Helicos BioSciences Corporation (NASDAQ:HLCS) today announced the launch of the HeliSphere(TM) Technology Center, an open access Web site Genetic Analysis System; competition; changing technology and customer requirements; our ability to...
RXi Pharmaceuticals Reports Financial Results for the Third Quarter of 2008
WORCESTER, Mass.-(Business Wire)-November 14, 2008 - RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported results for the quarter ended September 30...
Unigene Laboratories, Inc. Joins Scrip World's Biotechnology Top Fifty
FAIRFIELD, N.J.-(Business Wire)-November 14, 2008 - Unigene Laboratories, Inc. (OTCBB: UGNE, http:// www.unigene.com), a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs, has been included in the Scrip World Pharmaceutical News "Company League Tables...
Search Our News Using Google Search
Can't find what you want? Try using Google:
